Dataset Information


DreamTel; Diabetes risk evaluation and management tele-monitoring study protocol.

ABSTRACT: The rising prevalence of type 2 diabetes underlines the importance of secondary strategies for the prevention of target organ damage. While access to diabetes education centers and diabetes intensification management has been shown to improve blood glucose control, these services are not available to all that require them, particularly in rural and northern areas. The provision of these services through the Home Care team is an advance that can overcome these barriers. Transfer of blood glucose data electronically from the home to the health care provider may improve diabetes management.The study population will consist of patients with type 2 diabetes with uncontrolled A1c levels living on reserve in the Battlefords region of Saskatchewan, Canada. This pilot study will take place over three phases. In the first phase over three months the impact of the introduction of the Bluetooth enabled glucose monitor will be assessed. In the second phase over three months, the development of guidelines based treatment algorithms for diabetes intensification will be completed. In the third phase lasting 18 months, study subjects will have diabetes intensification according to the algorithms developed.The first phase will determine if the use of the Bluetooth enabled blood glucose devices which can transmit results electronically will lead to changes in A1c levels. It will also determine the feasibility of recruiting subjects to use this technology. The rest of the Diabetes Risk Evaluation and Management Tele-monitoring (DreamTel) study will determine if the delivery of a diabetes intensification management program by the Home Care team supported by the Bluetooth enabled glucose meters leads to improvements in diabetes management.Protocol NCT00325624.


PROVIDER: S-EPMC2689225 | BioStudies | 2009-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2013-01-01 | S-EPMC3628059 | BioStudies
2010-01-01 | S-EPMC2827492 | BioStudies
2005-01-01 | S-EPMC546416 | BioStudies
2012-01-01 | S-EPMC3467590 | BioStudies
2018-01-01 | S-EPMC6286423 | BioStudies
2020-01-01 | S-EPMC7093767 | BioStudies
2020-01-01 | S-EPMC7189156 | BioStudies
2008-01-01 | S-EPMC2585658 | BioStudies
2019-01-01 | S-EPMC6803884 | BioStudies
1000-01-01 | S-EPMC4528987 | BioStudies